NVP-CGM-097 is primarily investigated for its potential in cancer therapy, particularly in targeting specific pathways involved in tumor growth and survival. It functions as a potent inhibitor of certain protein-protein interactions that are critical for the regulation of cell cycle and apoptosis in cancer cells. By disrupting these interactions, NVP-CGM-097 aims to induce cancer cell death and inhibit tumor progression. Its application is being explored in preclinical and clinical studies to evaluate its efficacy and safety in treating various types of cancers, including those resistant to conventional therapies. Additionally, it holds promise for combination therapies, potentially enhancing the effectiveness of existing treatments.